Skip to content
drillr.ai
Sign up

PFE

PFIZER INC

NYSE · Healthcare · Drug Manufacturers - General · US

$27.60
−0.14%
Ask drillr

  • Sep 19, 2026, 11:00 UTC

    The Delhi High Court ruled that a ₹1,851 crore payment made by Ranbaxy Laboratories to Teva Israel under a settlement agreement is not taxable in India, allowing Teva Israel's refund subject to guarantees.

    Source:

  • Sep 19, 2026, 11:00 UTC

    Public Citizen sued the Trump administration under the Freedom of Information Act to obtain documents on confidential drug-pricing deals with Pfizer and Eli Lilly, and is litigating to challenge the administration's redactions.

    Source:

  • Sep 17, 2026, 17:31 UTC

    Health Canada approved Pfizer's XFG-adapted COVID-19 vaccine.

    Source:

  • Sep 17, 2026, 17:30 UTC

    Health Canada approved the Pfizer-BioNTech COVID-19 vaccine adapted for the Omicron XBB variant.

    Source:

  • Sep 17, 2026, 07:15 UTC

    Bavarian Nordic A/S appointed Tarja Stenvall as President and Chief Executive Officer effective October 15, 2026, succeeding Paul Chaplin.

    Source:

  • Sep 15, 2026, 17:00 UTC

    Ireland's High Court appointed Colin Gaynor of Resolute Advisory as provisional liquidator of Waterford-based virtual reality company Engage XR after it became unable to continue trading following the loss of three major customers.

    Source:

  • Sep 15, 2026, 09:30 UTC

    India's Special Investigation Team traced suspected spurious and mislabelled medicines, including counterfeit Pfizer products, cancer drugs and ICU injections, to more than 90 hospitals and clinics in Bengaluru and nearby areas, centering on a licensed pharmacist who allegedly used a legitimate pharmaceutical business to build a distribution network reaching Maharashtra and Gujarat.

    Source:

  • Sep 7, 2026, 07:45 UTC

    Novartis India Ltd announced the acquisition of the Minipress and Minipres trademarks in India and related intellectual property rights from Pfizer Inc and Pfizer Products Inc USA for Rs 1,250 crore.

    Source:

  • Sep 7, 2026, 05:57 UTC

    Pfizer Inc. will discontinue the marketing and distribution of Minipress XL.

    Source:

  • Sep 4, 2026, 21:15 UTC

    Texas Attorney General Ken Paxton asked a federal appeals court to reinstate his lawsuit against Pfizer over COVID-19 vaccine efficacy claims, after a lower court dismissed the case on immunity grounds.

    Source:

  • Sep 4, 2026, 14:15 UTC

    Pfizer paid shareholders $0.43 per share on September 1, 2026, the fourth consecutive quarter at that rate, maintaining its annual dividend of $1.72 per share.

    Source:

  • Sep 3, 2026, 12:03 UTC

    Medicus Pharma Ltd. signed a Co-Development and License Agreement with Pfizer Inc., under which Pfizer granted Medicus an exclusive worldwide license to develop, manufacture and commercialize PF-08046031 (CD228V), with Medicus paying a $12.0 million upfront fee and Pfizer paying a $2.0 million development funding payment.

  • Aug 27, 2026, 20:30 UTC

    The U.S. FDA approved the supplemental Biologics License Application for Pfizer and BioNTech's 2026-2027 COVID-19 vaccine formula targeting the XFG variant, for use in adults aged 65 and older and individuals aged 5-64 with high-risk conditions.

    Source:

  • Aug 25, 2026, 09:55 UTC

    Bank of Nova Scotia reduced its stake in Pfizer Inc. by 13.4% during the quarter, selling 683,496 shares and retaining 4,423,296 shares, as disclosed in a 13F filing.

    Source:

  • Aug 23, 2026, 08:53 UTC

    Danske Bank A/S increased its stake in Pfizer Inc. by 9.2% during the second quarter of 2026, purchasing an additional 309,400 shares, as disclosed in its 13F filing with the SEC.

    Source:

  • Aug 23, 2026, 08:20 UTC

    Edmond DE Rothschild Holding S.A. sold 128,428 shares of Pfizer Inc., reducing its stake by 8.1% during the quarter, according to its SEC filing.

    Source:

  • Aug 22, 2026, 10:45 UTC

    BlackRock Inc. increased its stake in Pfizer Inc. by 6.3% during the second quarter, acquiring an additional 31,412,883 shares, as disclosed in its Form 13F filing with the SEC.

    Source:

  • Aug 22, 2026, 07:10 UTC

    AMG National Trust Bank reduced its stake in Pfizer Inc. by 30.2% during the second quarter of 2026, selling 27,369 shares and retaining 63,296 shares, as disclosed in a recent SEC filing.

    Source:

  • Aug 21, 2026, 09:15 UTC

    Russell Investments Group Ltd. increased its stake in Pfizer Inc. by 15.7% during the second quarter, acquiring 745,213 additional shares, according to its Form 13F filing.

    Source:

  • Aug 20, 2026, 10:04 UTC

    Ingrid Zhang, Chief Commercial Officer International at Novartis, decided to leave the company to pursue external opportunities, announced via an internal memo on August 19, 2026.

    Source:

  • Aug 20, 2026, 06:00 UTC

    Kenyan President William Ruto announced plans to meet Pfizer leadership to negotiate lower prices for life-saving medicines in Kenya.

    Source:

  • Aug 19, 2026, 09:15 UTC

    Central Carolina Community College opened the E. Eugene Moore Manufacturing and Biotech Solutions Center in Lee County, North Carolina, with a ribbon-cutting ceremony, unveiling the Kyowa Kirin Innovation Hub.

    Source:

  • Aug 14, 2026, 17:45 UTC

    Pfizer CEO Albert Bourla purchased $1 million worth of Pfizer stock, capping a post-earnings insider buying spree by three Pfizer insiders.

    Source:

  • Aug 4, 2026, 11:15 UTC

    Pfizer declared a quarterly dividend of $0.43 per share, unchanged from the prior-year period.

    Source:
Page 1Next →